Avoid the stress of overpaying for a stock or missing an opportunity by using the right tools and insights to evaluate Nuvation Bio Inc. before investing.

In this article, we go over a few key elements for understanding Nuvation Bio Inc.’s stock price such as:

• Nuvation Bio Inc.’s current stock price and volume
• Why Nuvation Bio Inc.’s stock price changed recently
• Upgrades and downgrades for NUVB from analysts
• NUVB’s stock price momentum as measured by its relative strength

About Nuvation Bio Inc. (NUVB)

Before we jump into Nuvation Bio Inc.’s stock price, history, target price and what caused it to recently rise, let’s take a look at some background.

Nuvation Bio Inc., a clinical-stage biopharmaceutical company, focuses on developing therapeutic candidates for oncology. Its lead product candidate is taletrectinib, an ROS1 inhibitor for the treatment of patients with ROS1+ non-small cell lung cancer. The company is also developing Safusidenib, an inhibitor of mutant isocitrate dehydrogenase 1 in phase 2 clinical trials; NUV-1511, a drug-drug conjugate for use in chemotherapy agent that suppresses the growth of various advanced solid tumors; and NUV-868, a binding domain 2 bromodomain and extra-terminal inhibitor that inhibits bromodomain-containing protein 4. The company was founded in 2018 and is headquartered in New York, New York.

Want to learn more about Nuvation Bio Inc.’s stock? Click the button below to subscribe to A+ Investor and get access to everything you need to know about Nuvation Bio Inc..

Nuvation Bio Inc.’s Stock Price as of Market Close

As of November 28, 2025, 1:00 PM, CST, Nuvation Bio Inc.’s stock price was $8.030.

Nuvation Bio Inc. is up 0.25% from its previous closing price of $8.010.

During the last market session, Nuvation Bio Inc.’s stock traded between $7.910 and $8.140. Currently, there are approximately 342.39 million shares outstanding for Nuvation Bio Inc..

Nuvation Bio Inc.’s trailing earnings per share are negative, so the stock does not have a meaningful P/E ratio. We suggest investors evaluate other financial metrics to understand its overall valuation.

Nuvation Bio Inc. Stock Price History

Nuvation Bio Inc.’s (NUVB) price is currently up 53.83% so far this month.

During the month of November, Nuvation Bio Inc.’s stock price has reached a high of $8.240 and a low of $3.920.

Over the last year, Nuvation Bio Inc. has hit prices as high as $8.240 and as low as $1.540. Year to date, Nuvation Bio Inc.’s stock is up 201.88%.

Sign Up to Receive a Free Special Report Showing How A+ Grades Can Help You Make Smarter Investment Decisions

What Caused Nuvation Bio Inc. Stock’s Price to Rise?

Stock prices are primarily based on seller supply and buyer demand. But have you ever wondered about what other factors affect a stock's price?

One of the most common factors that can drastically impact a stock’s price is analyst upgrades and downgrades. When an analyst changes their opinion of a stock by upgrading or downgrading their rating, it often leads to a sudden stock price adjustment. However, as of November 28, 2025,, no analysts have changed their rating of Nuvation Bio Inc.’s stock over the last month.

Additionally, you'll want to evaluate Nuvation Bio Inc.’s financial health and valuation. Investors can use AAII's Value Grade, which combines six key valuation metrics like P/E and P/S ratios for a comprehensive analysis to conduct analysis on Nuvation Bio Inc.’s valuation and financial health. This approach mitigates the limitations of single-metric evaluations.

Nuvation Bio Inc.’s current valuation based on AAII’s Value Grade is a F, which means it is considered to be Ultra Expensive.

Learn how to evaluate stocks with AAII Grades and Scores with A+ Investor today.

Lastly, news and media coverage as well as recent press reports about the company or its industry may cause stock prices to fluctuate. You can check out the most recent news articles about Nuvation Bio Inc. (NUVB) by visiting AAII Stock Evaluator.

Relative Price Strength of Nuvation Bio Inc.

Relative price strength measures a stock's performance against the market, helping investors identify stocks that are outperforming benchmarks.

For AAII’s Momentum Grade, a weighted relative price strength is calculated. Follow this link to learn more about the Momentum Grade.

As of November 28, 2025, Nuvation Bio Inc. has a weighted four-quarter relative price strength of 63.37%, which translates to a Momentum Score of 99 and is considered to be Very Strong.

Want to learn more about how Nuvation Bio Inc. is graded based on AAII’s composite scores for value, growth, quality and earnings estimate revisions? Subscribe to A+ Investor today.

Nuvation Bio Inc. Stock Price: Bottom Line

As of November 28, 2025, Nuvation Bio Inc.’s stock price is $8.030, which is up 0.25% from its previous closing price.

AAII advises against making stock decisions based solely on price or past returns. Instead, consider a variety of metrics, fundamentals, and analytics to evaluate a stock like Nuvation Bio Inc. stock prices are influenced by market supply and demand and offer just a snapshot of a company's overall health.

Subscribing to AAII's A+ Investor provides access to comprehensive analytics and insights for confident investing.